Announcements in Conjunction With Theratechnologies Annual Meeting - Seite 2

“I want to take this opportunity to thank Luc Tanguay, our former President and Chief Executive Officer, who left the Company after 24 years of service. Through Luc’s leadership, Theratechnologies became a commercial-stage biopharmaceutical company with presence in the United States and Europe. He was also behind the repurchase of the rights to EGRIFTA, the acquisition of the commercial rights to Trogarzo in the United States and Europe and the transaction to acquire our SORT1+ oncology technology,” added Ms. Svoronos.

“Finally, I would like to officially welcome Paul Lévesque as our new President and Chief Executive Officer. Paul brings a thorough knowledge and understanding of the global pharmaceutical industry. I have no doubt that he will take this Company to new heights,” concluded Ms. Svoronos.

“I have joined a company with enormous potential both from a short- and long-term perspective. About 100 days into the job, I am more convinced that we have tremendous commercial assets and a great pipeline which will continue to bring and drive growth. We have great ambitions and we are uniquely positioned to deliver on them,” said Paul Lévesque, President and CEO, Theratechnologies.

Speeches recorded
Today’s Annual Meeting of Shareholders was mistakenly ended by the operator of virtual platform after the formal part of the meeting. Speeches from Ms. Dawn Svoronos, Chair of the Board, and Mr. Paul Lévesque, President and Chief Executive Officer, which were supposed to be delivered during the informal part of the meeting, have been recorded and will be available on our website at www.theratech.com as of 2 p.m. today.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a commercial-stage biopharmaceutical company addressing unmet medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those living with HIV. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov

Forward-Looking Information
This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s beliefs and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as "may", "will", "should", "could", “would”, "outlook", "believe", "plan", "envisage", "anticipate", "expect" and "estimate", or the negatives of these terms, or variations of them. The forward-looking statements contained in this press release include, but are not limited to, statements regarding our growth and the potential of our pipeline.